U.S. ranks first in supporting global life science innovation
Rumors swirl of LabCorp’s potential acquisition of INC Research
Already a subscriber?
Log in to your digital subscription.
Subscribe to CWWeekly.
Facing protocol amendments head-on
Cycle time and cost impact shining light on avoidable amendments
The long wave goodbye to phantom PIs
FDA and industry tackling disengaged PIs, but more to be done
Slow to negative growth in select emerging markets
Latin America and India markets have been contracting
CROs juggle proprietary and commercial systems
Adopt customized EDC and CTMS while offering own niche solutions
Purchase a single issue.
Subscribe to The CenterWatch Monthly.